200 related articles for article (PubMed ID: 32913893)
41. Exploring the different states of wild-type T-cell receptor and mutant conformational changes towards understanding the antigen recognition.
Tripathi SK; Salunke DM
J Biomol Struct Dyn; 2021 Jan; 39(1):188-201. PubMed ID: 31870204
[TBL] [Abstract][Full Text] [Related]
42. Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects.
Shafer P; Kelly LM; Hoyos V
Front Immunol; 2022; 13():835762. PubMed ID: 35309357
[TBL] [Abstract][Full Text] [Related]
43. Evidence for a TCR affinity threshold delimiting maximal CD8 T cell function.
Schmid DA; Irving MB; Posevitz V; Hebeisen M; Posevitz-Fejfar A; Sarria JC; Gomez-Eerland R; Thome M; Schumacher TN; Romero P; Speiser DE; Zoete V; Michielin O; Rufer N
J Immunol; 2010 May; 184(9):4936-46. PubMed ID: 20351194
[TBL] [Abstract][Full Text] [Related]
44. TCR-like antibodies targeting autoantigen-mhc complexes: a mini-review.
Li Y; Jiang W; Mellins ED
Front Immunol; 2022; 13():968432. PubMed ID: 35967436
[TBL] [Abstract][Full Text] [Related]
45. CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins.
Jost C; Darowski D; Challier J; Pulko V; Hanisch LJ; Xu W; Mössner E; Bujotzek A; Klostermann S; Umana P; Kontermann RE; Klein C
MAbs; 2020; 12(1):1840709. PubMed ID: 33136521
[TBL] [Abstract][Full Text] [Related]
46. Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro.
Gee MH; Sibener LV; Birnbaum ME; Jude KM; Yang X; Fernandes RA; Mendoza JL; Glassman CR; Garcia KC
Proc Natl Acad Sci U S A; 2018 Jul; 115(31):E7369-E7378. PubMed ID: 30021852
[TBL] [Abstract][Full Text] [Related]
47. T-cell Receptors Engineered
Sharma P; Harris DT; Stone JD; Kranz DM
Cancer Immunol Res; 2019 Dec; 7(12):2025-2035. PubMed ID: 31548259
[TBL] [Abstract][Full Text] [Related]
48. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein.
Chaurasia P; Nguyen THO; Rowntree LC; Juno JA; Wheatley AK; Kent SJ; Kedzierska K; Rossjohn J; Petersen J
J Biol Chem; 2021 Sep; 297(3):101065. PubMed ID: 34384783
[TBL] [Abstract][Full Text] [Related]
49. ERAP2 supports TCR recognition of three immunotherapy targeted tumor epitopes.
Schmidt K; Leisegang M; Kloetzel PM
Mol Immunol; 2023 Feb; 154():61-68. PubMed ID: 36608422
[TBL] [Abstract][Full Text] [Related]
50. Characterization of amino acid residues of T-cell receptors interacting with HLA-A*02-restricted antigen peptides.
Zhu Y; Huang C; Su M; Ge Z; Gao L; Shi Y; Wang X; Chen J
Ann Transl Med; 2021 Mar; 9(6):495. PubMed ID: 33850892
[TBL] [Abstract][Full Text] [Related]
51. T-cell-receptor cross-recognition and strategies to select safe T-cell receptors for clinical translation.
Bentzen AK; Hadrup SR
Immunooncol Technol; 2019 Sep; 2():1-10. PubMed ID: 35036898
[TBL] [Abstract][Full Text] [Related]
52. Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness.
Irving M; Zoete V; Hebeisen M; Schmid D; Baumgartner P; Guillaume P; Romero P; Speiser D; Luescher I; Rufer N; Michielin O
J Biol Chem; 2012 Jun; 287(27):23068-78. PubMed ID: 22549784
[TBL] [Abstract][Full Text] [Related]
53. Tuning T cell receptor sensitivity through catch bond engineering.
Zhao X; Kolawole EM; Chan W; Feng Y; Yang X; Gee MH; Jude KM; Sibener LV; Fordyce PM; Germain RN; Evavold BD; Garcia KC
Science; 2022 Apr; 376(6589):eabl5282. PubMed ID: 35389803
[TBL] [Abstract][Full Text] [Related]
54. TCR Fingerprinting and Off-Target Peptide Identification.
Karapetyan AR; Chaipan C; Winkelbach K; Wimberger S; Jeong JS; Joshi B; Stein RB; Underwood D; Castle JC; van Dijk M; Seibert V
Front Immunol; 2019; 10():2501. PubMed ID: 31695703
[TBL] [Abstract][Full Text] [Related]
55. A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.
Sullivan LC; Walpole NG; Farenc C; Pietra G; Sum MJW; Clements CS; Lee EJ; Beddoe T; Falco M; Mingari MC; Moretta L; Gras S; Rossjohn J; Brooks AG
J Biol Chem; 2017 Dec; 292(51):21149-21158. PubMed ID: 28972140
[TBL] [Abstract][Full Text] [Related]
56. Rational development of high-affinity T-cell receptor-like antibodies.
Stewart-Jones G; Wadle A; Hombach A; Shenderov E; Held G; Fischer E; Kleber S; Nuber N; Stenner-Liewen F; Bauer S; McMichael A; Knuth A; Abken H; Hombach AA; Cerundolo V; Jones EY; Renner C
Proc Natl Acad Sci U S A; 2009 Apr; 106(14):5784-8. PubMed ID: 19307587
[TBL] [Abstract][Full Text] [Related]
57. Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen.
Thomas S; Xue SA; Bangham CR; Jakobsen BK; Morris EC; Stauss HJ
Blood; 2011 Jul; 118(2):319-29. PubMed ID: 21606483
[TBL] [Abstract][Full Text] [Related]
58. Defining virus-specific CD8+ TCR repertoires for therapeutic regeneration of T cells against chronic hepatitis E.
Soon CF; Behrendt P; Todt D; Manns MP; Wedemeyer H; Sällberg Chen M; Cornberg M
J Hepatol; 2019 Oct; 71(4):673-684. PubMed ID: 31203151
[TBL] [Abstract][Full Text] [Related]
59. TCRs used in cancer gene therapy cross-react with MART-1/Melan-A tumor antigens via distinct mechanisms.
Borbulevych OY; Santhanagopolan SM; Hossain M; Baker BM
J Immunol; 2011 Sep; 187(5):2453-63. PubMed ID: 21795600
[TBL] [Abstract][Full Text] [Related]
60. Structure of the Vdelta domain of a human gammadelta T-cell antigen receptor.
Li H; Lebedeva MI; Llera AS; Fields BA; Brenner MB; Mariuzza RA
Nature; 1998 Jan; 391(6666):502-6. PubMed ID: 9461220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
